MOWI Mowi ASA

Mowi ASA (OSE:MOWI): Q1 2023 Trading update

Mowi ASA (OSE:MOWI): Q1 2023 Trading update

Harvest volumes Q1 2023 (1)

Farming Norway65.5 thousand tonnes
Farming Scotland11.0 thousand tonnes
Farming Chile10.5 thousand tonnes
Farming Canada7.5 thousand tonnes
Farming Ireland1.0 thousand tonnes
Farming Faroes2.0 thousand tonnes
Farming Iceland (Arctic Fish)5.0 thousand tonnes
Total102.5 thousand tonnes
  

In connection with the presentation of the Q4 2022 results, Mowi ASA guided a total harvest volume of 98 thousand tonnes (GWE) for Q1 2023.

Note:

(1) The harvest volumes are provided in gutted weight equivalents (GWE).

Additional information

Operational EBIT for the Group was approximately EUR 322 million in Q1 2023 (EUR 207 million in Q1 2022).

Total Operational EBIT per kg through the value chain was approximately as follows:

NorwayEUR3.75
ScotlandEUR2.45
ChileEUR1.50
CanadaEUR2.15   
IrelandEUR1.70
FaroesEUR3.30
IcelandEUR2.10
   

Operational EBIT in Consumer Products was EUR 37 million (EUR 21 million in Q1 2022). Operational EBITDA in Feed was EUR 6 million in Q1 2023 (EUR 1 million in Q1 2022).

Reported financial net interest-bearing debt (NIBD) for the group was approximately EUR 1 640 million at the end of the quarter (excluding IFRS 16 effects), of which EUR 79 million in Arctic Fish.

The complete Q1 2023 report will be released on 10 May at 06:30 CET.

Please refer to the Annual Report for detailed descriptions and reconciliations of non-IFRS measures such as Operational EBIT and NIBD.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.



EN
18/04/2023

Underlying

MOWIMowi ASA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mowi ASA

 PRESS RELEASE
Free
MOWI MOWI ASA

Mowi ASA (OSE:MOWI): Board changes

Mowi ASA (OSE:MOWI): Board changes Today, on 27 February 2026, Ørjan Svanevik has resigned from his position as Chair of the Board of Mowi ASA. The resignation as Chair of the Board is the result of Svanevik´s termination of his employment with Seatankers Management, an associated company of Geveran Trading Co. Ltd, and will be effective immediately. The nomination committee has been informed of Svanevik´s resignation and thanks him for his service. The remaining board members will constitute a quorum. The Vice Chair of the Board, Leif Teksum, will take the position as Intermediate Chair...

February 27, 2026 1 EN
Alexander Aukner
  • Alexander Aukner
BMK BENCHMARK HOLDINGS
LSG LEROY SEAFOOD GROUP ASA
AUSS AUSTEVOLL SEAFOOD ASA
AKVA AKVA GROUP ASA
SALM SALMAR ASA
GSF GRIEG SEAFOOD ASA
MOWI MOWI ASA
BAKKA BAKKAFROST P/F
SALMOCAM SALMONES CAMANCHACA SA
IFISH ICE FISH FARM AS
ASA ATLANTIC SAPPHIRE
SALME SALMON EVOLUTION HOLDING
KING THE KINGFISH COMPANY NV
AKBM AKER BIOMARINE
ISLAX ARNARLAX AS
AFISH ARCTIC FISH HOLDING AS
MAS MÅSØVAL
02/27/26 February 27, 2026 1 EN
Alexander Aukner
  • Alexander Aukner
LSG LEROY SEAFOOD GROUP ASA
AUSS AUSTEVOLL SEAFOOD ASA
SALM SALMAR ASA
GSF GRIEG SEAFOOD ASA
MOWI MOWI ASA
BAKKA BAKKAFROST P/F
SALMOCAM SALMONES CAMANCHACA SA
IFISH ICE FISH FARM AS
ISLAX ARNARLAX AS
AFISH ARCTIC FISH HOLDING AS
MAS MÅSØVAL
02/26/26 February 26, 2026 1 EN
Alexander Aukner
  • Alexander Aukner
BMK BENCHMARK HOLDINGS
LSG LEROY SEAFOOD GROUP ASA
AUSS AUSTEVOLL SEAFOOD ASA
AKVA AKVA GROUP ASA
SALM SALMAR ASA
GSF GRIEG SEAFOOD ASA
MOWI MOWI ASA
BAKKA BAKKAFROST P/F
SALMOCAM SALMONES CAMANCHACA SA
IFISH ICE FISH FARM AS
ASA ATLANTIC SAPPHIRE
SALME SALMON EVOLUTION HOLDING
KING THE KINGFISH COMPANY NV
AKBM AKER BIOMARINE
ISLAX ARNARLAX AS
AFISH ARCTIC FISH HOLDING AS
MAS MÅSØVAL
02/20/26 February 20, 2026 1 EN
Alexander Aukner
  • Alexander Aukner
LSG LEROY SEAFOOD GROUP ASA
AUSS AUSTEVOLL SEAFOOD ASA
SALM SALMAR ASA
GSF GRIEG SEAFOOD ASA
MOWI MOWI ASA
BAKKA BAKKAFROST P/F
SALMOCAM SALMONES CAMANCHACA SA
IFISH ICE FISH FARM AS
ISLAX ARNARLAX AS
AFISH ARCTIC FISH HOLDING AS
MAS MÅSØVAL
02/20/26 February 20, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch